ArticleEuropean journal of rheumatology2026
Nemaline Myopathy in Systemic Lupus Erythematosus.
Article in European journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sporadic late-onset nemaline myopathy (SLONM) is a rare muscle disorder that can be treated or may pose a potential threat to life. It usually manifests in the later stages of life and is characterized by the accumulation of nemaline rods within muscle fibers. The pathophysiology of this disease is still not fully understood, with some evidence suggesting that autoimmune responses and hematological neoplasia may be involved. Herein, a case of SLONM associated with systemic lupus erythematosus is presented, which showed a favorable response to immunotherapy. Cite this article as: Cui R, Luan X, Dai S. Nemaline myopathy in systemic lupus erythematosus. Eur J Rheumatol. 2026, 13(2), 0048, doi:10.5152/eurjrheum.2026.25045.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.